Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPEPLD | Q6IQ20 | 9/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.40 |
| ▸ | RET | P07949 | 1/20 | 0.40 |
| ▸ | RBP4 | P02753 | 2/20 | 0.39 |
| ▸ | TTR | P02766 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL342591 | 0.87 | KDM4E (0.57) | KDM4EHSD17B10MEN1ALDH1A1KMT2A | |
| Trifluoroacetic Acid SCHEMBL341448 | 0.87 | KDM4E (0.57) | KDM4EHSD17B10MEN1ALDH1A1KMT2A | |
| Trifluoroacetic Acid SCHEMBL474405 | 0.86 | AURKA (0.40) | KDM4EHSD17B10MEN1ALDH1A1KMT2A | |
| Trifluoroacetic Acid SCHEMBL342173 | 0.86 | AURKA (0.40) | KDM4EHSD17B10MEN1ALDH1A1KMT2A | |
| Trifluoroacetic Acid SCHEMBL342171 | 0.86 | AURKA (0.40) | KDM4EHSD17B10MEN1ALDH1A1KMT2A | |
| Trifluoroacetic Acid SCHEMBL343048 | 0.85 | AURKA (0.40) | AURKAAURKBINCENPRETRBP4 | |
| Trifluoroacetic Acid SCHEMBL343047 | 0.85 | AURKA (0.40) | AURKAAURKBINCENPRETRBP4 | |
| SCHEMBL473587 | 0.81 | KDM4E (0.64) | KDM4EHSD17B10MEN1ALDH1A1KMT2A | |
| SCHEMBL342172 | 0.81 | AURKA (0.37) | AURKAAURKBINCENPRETRBP4 | |
| SCHEMBL14670320 | 0.81 | HSD17B10 (0.48) | KDM4EHSD17B10MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367690-B2 | Aminopyridine derivatives having aurora a selective inhibitory action | VERTEX PHARMACEUTICALS INC. (US) | 2013-02-05 | — | — | US | disclosed |
| US-20120015969-A1 | NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION | BANYU PHARMACEUTICALS CO., LTD. (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015969-A1 | NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION | AURKA, AURKC, AURKB | NAPEPLD 3355/4885KDM4E 621/4885HSD17B10 1328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.